N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia
出版年份 2022 全文链接
标题
N-Acetylcysteine and Aripiprazole Improve Social Behavior and Cognition and Modulate Brain BDNF Levels in a Rat Model of Schizophrenia
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 4, Pages 2125
出版商
MDPI AG
发表日期
2022-02-16
DOI
10.3390/ijms23042125
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- N ‐acetylcysteine for depression and glutamate changes in the left prefrontal cortex in adolescents and young adults at risk for bipolar disorder: A pilot study
- (2021) Fabiano G. Nery et al. Early Intervention in Psychiatry
- Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague–Dawley Rats
- (2021) Marta Anna Lech et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Impact of repeated co-treatment with escitalopram and aripiprazole on the schizophrenia-like behaviors and BDNF mRNA expression in the adult Sprague–Dawley rats exposed to glutathione deficit during early postnatal development of the brain
- (2021) Marta A. Lech et al. Pharmacological Reports
- Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
- (2021) Lena Palaniyappan et al. Antioxidants
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex
- (2020) Marta Hereta et al. BEHAVIOURAL BRAIN RESEARCH
- Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis
- (2019) Anna M. Wang et al. JAMA Psychiatry
- The glutathione cycle shapes synaptic glutamate activity
- (2019) Thomas W. Sedlak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Co-treatment with antidepressants and aripiprazole reversed the MK-801-induced some negative symptoms of schizophrenia in rats
- (2019) Marta Hereta et al. Pharmacological Reports
- NMDAR Hypofunction Animal Models of Schizophrenia
- (2019) Gloria Lee et al. Frontiers in Molecular Neuroscience
- Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats
- (2019) Magdalena Górny et al. MOLECULES
- Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review
- (2018) Caitlin O. B. Yolland et al. NUTRITIONAL NEUROSCIENCE
- Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione
- (2018) Tushar Kanti Das et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
- (2018) Alan Breier et al. SCHIZOPHRENIA RESEARCH
- Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
- (2018) Kouji Fukuyama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effect of N-acetylcysteine (NAC) on human cognition – A systematic review
- (2017) David R. Skvarc et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
- (2017) Philippe Conus et al. SCHIZOPHRENIA BULLETIN
- N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
- (2016) Alessandro Minarini et al. Expert Opinion on Drug Metabolism & Toxicology
- Cognitive effects of adjunctive N-acetyl cysteine in psychosis
- (2016) M. Rapado-Castro et al. PSYCHOLOGICAL MEDICINE
- Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models
- (2016) Paula Moran et al. NEURAL PLASTICITY
- Main path and byways: non-vesicular glutamate release by system xc−as an important modifier of glutamatergic neurotransmission
- (2015) Ann Massie et al. JOURNAL OF NEUROCHEMISTRY
- DNA Methylation in Memory Formation
- (2015) Frankie D. Heyward et al. NEUROSCIENTIST
- The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats
- (2015) Katarzyna Kamińska et al. Pharmacological Reports
- Prenatal LPS-exposure – a neurodevelopmental rat model of schizophrenia – differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring
- (2015) Lena Wischhof et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
- (2015) Kim Q. Do et al. SCHIZOPHRENIA BULLETIN
- The Longitudinal Course of Cognitive Impairment in Schizophrenia
- (2014) Richard S. E. Keefe JOURNAL OF CLINICAL PSYCHIATRY
- The Early Longitudinal Course of Cognitive Deficits in Schizophrenia
- (2014) Keith H. Nuechterlein et al. JOURNAL OF CLINICAL PSYCHIATRY
- N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
- (2014) Olivia Dean et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- Neurodevelopmental model of schizophrenia: update 2012
- (2012) J L Rapoport et al. MOLECULAR PSYCHIATRY
- Glutathione is a physiologic reservoir of neuronal glutamate
- (2011) Minori Koga et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission
- (2011) Shunsuke Tanahashi et al. NEUROPHARMACOLOGY
- Postnatal Developmental Trajectories of Neural Circuits in the Primate Prefrontal Cortex: Identifying Sensitive Periods for Vulnerability to Schizophrenia
- (2011) G. D. Hoftman et al. SCHIZOPHRENIA BULLETIN
- Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
- (2010) Daisuke Matsuzawa et al. ANTIOXIDANTS & REDOX SIGNALING
- Childhood onset schizophrenia: support for a progressive neurodevelopmental disorder
- (2010) Judith L. Rapoport et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
- (2010) Jeremy W. Gawryluk et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The environment and schizophrenia
- (2010) Jim van Os et al. NATURE
- DNA methylation and memory formation
- (2010) Jeremy J Day et al. NATURE NEUROSCIENCE
- Animal models of neuropsychiatric disorders
- (2010) Eric J Nestler et al. NATURE NEUROSCIENCE
- Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway
- (2010) Daisuke Ishii et al. NEUROSCIENCE LETTERS
- Buthionine Sulfoximine, an Experimental Tool to Induce Glutathione Deficiency: Elucidation of Glutathione and Ascorbate in Their Role as Antioxidants
- (2010) Harry P. Broquist NUTRITION REVIEWS
- Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex
- (2010) Mirjana Carli et al. PSYCHOPHARMACOLOGY
- Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
- (2009) Daniel J. Lodge et al. BEHAVIOURAL BRAIN RESEARCH
- Brain weight in males is correlated with DNA methylation at IGF2
- (2009) R Pidsley et al. MOLECULAR PSYCHIATRY
- The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia
- (2008) Kuei Y. Tseng et al. BEHAVIOURAL BRAIN RESEARCH
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats
- (2008) Sung Woo Park et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Why do many psychiatric disorders emerge during adolescence?
- (2008) Tomáš Paus et al. NATURE REVIEWS NEUROSCIENCE
- Brain-Derived Neurotropic Factor/TrkB Signaling in the Pathogenesis and Novel Pharmacotherapy of Schizophrenia
- (2008) Anilkumar Pillai NEUROSIGNALS
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
- (2008) J. A. Lieberman et al. PHARMACOLOGICAL REVIEWS
- Gene-Environment Interactions in Schizophrenia: Review of Epidemiological Findings and Future Directions
- (2008) J. van Os et al. SCHIZOPHRENIA BULLETIN
- BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?
- (2007) Yuan Lu et al. NEUROBIOLOGY OF LEARNING AND MEMORY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now